µî·ÏÀÚ : dhrbdls
1. Çöº´·Â
2. ÀÚ·á¼öÁý
3. ½Åü°ËÁø
4. ¾à¹°¿ä¹ý
5. Ç÷¾×, ¿ä°Ë»ç
6. Áø´Ü °Ë»ç
7. ´ë»óÀÚ Áúº´ study
8. »ç·Ê ¿ä¾à, °£È£Áø´Ü ¸ñ·Ï
9. °£È£°úÁ¤ 2°³, ¿°Áõ °úÁ¤°ú °ü·ÃµÈ °íü¿Â, ¿°Áõ °úÁ¤°ú °ü·ÃµÈ ±Þ¼ºÅëÁõ
±³¼ö´Ô Çǵå¹é ¸ðµÎ ¼öÁ¤µÇ¾ú°í A+ ÀÚ·áÀÔ´Ï´Ù.
ĪÂù ¹Þ¾Ò°í ¼öÁ¤ »çÇ×µµ ¾ÆÁÖ Àû¾ú´ø ÀÚ·áÀÔ´Ï´Ù.
ÇÑ ¹ø »çµÎ¸é ÄÉÀ̽º Ʋ·Îµµ ¾ÆÁÖ Àß »ç¿ë °¡´ÉÇÕ´Ï´Ù.
(1) Çöº´·Â
¡Û °ú°Å·Â
- ÀÔ¿ø·Â: [2019-03-03~2019-03-12] MN / Lt. APN (Acute pyelonephritis)
[2023-05-26~2023-05-29] MN / Lt. APN (Acute pyelonephritis)
- º´·Â: NIDDM (Non-insulin-dependent diabetes mellitus) with retinopathy
(¸Á¸·º´ÁõÀ» µ¿¹ÝÇÑ Àν¶¸°-ºñÀÇÁ¸¼º ´ç´¢º´),
Dyslipidemia (ÀÌ»óÁöÁúÇ÷Áõ), hyperlipidemia (°íÁöÇ÷Áõ), Obesity (ºñ¸¸),
Mild depressive episode (°æµµ ¿ì¿ïÁõ)
- ¼ö¼ú·Â: [-] ¼ö±Ù°ü À¯¸®¼ú (¼Õ¸ñ ÅͳΠÁõÈıº ¼ö¼ú)
- Åõ¾à·Â: ÇǾƽºÇÁÇ÷º½ºÅÍÄ¡ÁÖ (DM), Æ®·¹½Ã¹ÙÇ÷º½ºÅÍÄ¡ÁÖ (DM), ÄÉÀ̹ٷÎÁ¤ (HL)
¡Û ÀÔ¿øÀÏ- »çÁ¤ Àü
DM type ¥± À¸·Î Insulin(30´ÜÀ§) Á¶Àý ÁßÀΠȯÀÚ·Î 8¿ù 26ÀÏ ¹ãºÎÅÍ ¿ÞÂÊ ¿·±¸¸® ÅëÁõ, ±ÙÀ°Åë, ¿ÀÇÑ Áõ»ó Áö¼ÓµÇ¾î º»¿ø ER ³»¿øÇÔ.
[2023-05-28 07:00] ER µµÂø: ´ç½Ã BT 38.7¡ÆC·Î chilling, myalgia È£¼ÒÇϼ̰í Lt. flank pain, Lt. CVA Td (Costovertebral angle Tenderness)·Î NRS 6Á¡ ÃøÁ¤µÊ.
[ÀÀ±ÞÁø·á°á°ú: ÀÔ¿ø] °Ë»ç °á°ú ¼³¸íÇÔ. CT»ó Lt. APN º¸ÀÌ°í ÀÖÀ¸¸ç ÀÌÀü 5¿ù¿¡ ÀÔ¿øÇßÀ» ¶§º¸´Ù CT »ó Inflammatory change ½ÉÇÏ¿© CRP 180´ë, Procalcitonin »ó½Â º¸ÀÌ°í ÀÖ¾î ÀÔ¿ø °·ÂÈ÷ ±ÇÀ¯ÇÔ. ȯÀÚ ÀÏ ¶§¹®¿¡ ÀÔ¿ø ºÒ°¡ÇÏ¿© °ÅºÎÇÏ´Â »óÅ·Π¾ÇÈ °¡´É¼º ¼³¸íÇÏ¿´°í ÀÏÇÏ´Â °÷ »çÀå´Ô°ú »óÀÇÇÏ¿© ÃÖÁ¾ ÀÔ¿ø °áÁ¤.
* ¹«·áÄíÆù ÀÚ·á°¡ ¾Æ´ÔÀ» ¾Ë·Áµå¸³´Ï´Ù.
¼ºÀΰ£È£ÇÐ, Á¦ 11ÆÇ, ±è¿Á¼ö ¿Ü (2020).
¼¿ï¾Æ»êº´¿ø
¾àÇÐÁ¤º¸¿ø
¹øÈ£ | Á¦¸ñ | ÆòÁ¡ | µî·ÏÀÏ |
---|
À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ Áø½Ç¼º¿¡ ´ëÇÏ¿© ÆÄÀ̾µà´Â º¸ÁõÇÏÁö ¾Æ´ÏÇϸç, ÇØ´ç Á¤º¸ ¹× °Ô½Ã¹° ÀúÀ۱ǰú ±âŸ ¹ýÀû Ã¥ÀÓÀº ÀÚ·á µî·ÏÀÚ¿¡°Ô ÀÖ½À´Ï´Ù. À§ Á¤º¸ ¹× °Ô½Ã¹° ³»¿ëÀÇ ºÒ¹ýÀû ÀÌ¿ë, ¹«´Ü ÀüÀ硤¹èÆ÷´Â ±ÝÁöµÇ¾î ÀÖ½À´Ï´Ù.ÀúÀÛ±ÇħÇØ, ¸í¿¹ÈÑ¼Õ µî ºÐÀï¿ä¼Ò ¹ß°ß½Ã °í°´¼¾ÅÍÀÇ ÀúÀÛ±ÇħÇØ ½Å°í¼¾Å͸¦ ÀÌ¿ëÇØ Áֽñ⠹ٶø´Ï´Ù.
ÀúÈñ ÆÄÀ̾µà´Â ±¸¸ÅÀÚ¿Í ÆǸÅÀÚ ¸ðµÎ°¡ ¸¸Á·ÇÏ´Â ¼ºñ½º°¡ µÇµµ·Ï, ÇϳªÀÇ °æ¿ì¶óµµ ¾Æ·¡ÀÇ ³»¿ë¿¡ ÇØ´çµÈ´Ù¸é ¹®ÀÇ Áï½Ã ±¸¸ÅÀڷḦ ȯºÒÇص帳´Ï´Ù.